Autopsy report · NCT02008123

Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant

“Inclusion/Exclusion criteria was too stringent to enroll patients at this site.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Dent Neuroscience Research Center

Sponsor type

University, hospital or other

Conditions

Clopidogrel Resistance; Secondary Stroke Prevention

Interventions

Primidone

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer
  “Too narrow inclusion criteria. Impossible to recruit patients.” (75% match in meaning)
• Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism
  “No patient corresponding to inclusion criteria couldn't be enrolled in the study” (71% match in meaning)
• Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
  “Could not enroll enough patients.” (70% match in meaning)
• Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation
  “Number of enrolled patients was insufficient during planned inclusion time.” (69% match in meaning)
• Study of Viscosupplementation for the Treatment of Knee Pain After Menisectomy
  “Patients did not meet inclusion criteria.” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.